Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.
Journal: Neuro-oncology practice
Published: March 09, 2026
A Scoping Review of Exercise Oncology in the Primary Brain Tumor Patient-Caregiver Dyad.
Journal: Current oncology (Toronto, Ont.)
Published: February 03, 2026
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025
A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.
Journal: Current oncology (Toronto, Ont.)
Published: July 25, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
Journal: Cancer research
Published: July 08, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI.
Journal: NPJ digital medicine
Published: April 11, 2025
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Journal: Neuro-oncology advances
Published: March 07, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Journal: Cancer discovery
Published: January 30, 2025
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
Journal: Neuro-oncology
Published: November 19, 2024
Last Updated: 09/26/2026